Brief: Better Therapeutics Announces Acceptance of Late Breaking Abstract For Its AspyreRx Pivotal Trial 180 Day Outcomes
04/03/2024 15:00
March 4 (Reuters) - Better Therapeutics Inc BTTX.O :
* BETTER THERAPEUTICS ANNOUNCES ACCEPTANCE OF LATE BREAKING
ABSTRACT FOR ITS ASPYRERX PIVOTAL TRIAL 180 DAY OUTCOMES AND
PARTICIPATION AT THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED
TECHNOLOGIES & TREATMENTS FOR DIABETES (ATTD)
Source text for Eikon: ID:nBw2Pcpl5a
Further company coverage: BTTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy